U-Blot® Research Grade Anti-Human CD283/TLR3 (IPH33)Cat. No. WA1540Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD283/TLR3 (IPH33)Cat. No. WA1540
U-Blot® Research Grade Anti-Human CD283/TLR3 (CNTO5429)Cat. No. WA1539
U-Blot® Research Grade Anti-Human CD283/TLR3 (CNTO-3157)Cat. No. WA1538
U-Blot® Research Grade Anti-Human CD28 (FR-104)Cat. No. WA1537
U-Blot® Research Grade Anti-Human CD279/PDCD1/PD1 (Sym021)Cat. No. WA1536
U-Blot® Research Grade Anti-Human CD279/PDCD1/PD1 (STT-002)Cat. No. WA1535
U-Blot® Research Grade Anti-Human CD279/PDCD1/PD1 (STI-1110)Cat. No. WA1534
U-Blot® Research Grade Anti-Human CD279/PDCD1/PD1 (SG001)Cat. No. WA1533
U-Blot® Research Grade Anti-Human CD279/PDCD1/PD1 (RTX-002)Cat. No. WA1532
U-Blot® Research Grade Anti-Human CD279/PDCD1/PD1 (MW11-h317)Cat. No. WA1531
U-Blot® Research Grade Anti-Human CD279/PDCD1/PD1 (LZM009)Cat. No. WA1530
U-Blot® Research Grade Anti-Human CD279/PDCD1/PD1 (LVGN3616)Cat. No. WA1529